Antibody data
- Antibody Data
- Antigen structure
- References [10]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 13734-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#13734-1-AP, RRID:AB_2202853
- Product name
- Trefoil factor 1 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated Trefoil factor 1 antibody (Cat. #13734-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references BAP18 facilitates CTCF-mediated chromatin accessible to regulate enhancer activity in breast cancer.
Resolving the difference between left-sided and right-sided colorectal cancer by single-cell sequencing.
Cell-Free Fat Extract Prevents Vaginal Atrophy in an Ovariectomized Model by Promoting Proliferation of Vaginal Keratinocytes and Neovascularization.
Trefoil factor-1 upregulation in estrogen-receptor positive breast cancer correlates with an increased risk of bone metastasis.
A novel chemical inhibitor suppresses breast cancer cell growth and metastasis through inhibiting HPIP oncoprotein.
Single-cell transcriptome analysis reveals differential nutrient absorption functions in human intestine.
Trefoil factor 1 (TFF1) is a potential prognostic biomarker with functional significance in breast cancers.
MORC2 regulates C/EBPα-mediated cell differentiation via sumoylation.
Trefoil factor 1 elevates the malignant phenotype of mucinous ovarian cancer cell through Wnt/β-catenin signaling.
Distinctions in gastric cancer gene expression signatures derived from laser capture microdissection versus histologic macrodissection.
Sun G, Wei Y, Zhou B, Wang M, Luan R, Bai Y, Li H, Wang S, Zheng D, Wang C, Wang S, Zeng K, Liu S, Lin L, He M, Zhang Q, Zhao Y
Cell death and differentiation 2023 May;30(5):1260-1278
Cell death and differentiation 2023 May;30(5):1260-1278
Resolving the difference between left-sided and right-sided colorectal cancer by single-cell sequencing.
Guo W, Zhang C, Wang X, Dou D, Chen D, Li J
JCI insight 2022 Jan 11;7(1)
JCI insight 2022 Jan 11;7(1)
Cell-Free Fat Extract Prevents Vaginal Atrophy in an Ovariectomized Model by Promoting Proliferation of Vaginal Keratinocytes and Neovascularization.
Kang B, Cai Y, Jia Z, Chen C, Deng M, Zhang W, Li W
Aesthetic surgery journal 2022 Jan 1;42(1):NP55-NP68
Aesthetic surgery journal 2022 Jan 1;42(1):NP55-NP68
Trefoil factor-1 upregulation in estrogen-receptor positive breast cancer correlates with an increased risk of bone metastasis.
Spadazzi C, Mercatali L, Esposito M, Wei Y, Liverani C, De Vita A, Miserocchi G, Carretta E, Zanoni M, Cocchi C, Bongiovanni A, Recine F, Kang Y, Ibrahim T
Bone 2021 Mar;144:115775
Bone 2021 Mar;144:115775
A novel chemical inhibitor suppresses breast cancer cell growth and metastasis through inhibiting HPIP oncoprotein.
Li P, Cao S, Huang Y, Zhang Y, Liu J, Cai X, Zhou L, Li J, Jiang Z, Ding L, Zheng Z, Li S, Ye Q
Cell death discovery 2021 Jul 29;7(1):198
Cell death discovery 2021 Jul 29;7(1):198
Single-cell transcriptome analysis reveals differential nutrient absorption functions in human intestine.
Wang Y, Song W, Wang J, Wang T, Xiong X, Qi Z, Fu W, Yang X, Chen YG
The Journal of experimental medicine 2020 Feb 3;217(2)
The Journal of experimental medicine 2020 Feb 3;217(2)
Trefoil factor 1 (TFF1) is a potential prognostic biomarker with functional significance in breast cancers.
Yi J, Ren L, Li D, Wu J, Li W, Du G, Wang J
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2020 Apr;124:109827
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2020 Apr;124:109827
MORC2 regulates C/EBPα-mediated cell differentiation via sumoylation.
Liu J, Zhang Q, Ruan B, Chen W, Zheng J, Xu B, Jiang P, Miao Z, Li F, Guo JY, Cao L, Wang G
Cell death and differentiation 2019 Oct;26(10):1905-1917
Cell death and differentiation 2019 Oct;26(10):1905-1917
Trefoil factor 1 elevates the malignant phenotype of mucinous ovarian cancer cell through Wnt/β-catenin signaling.
Zhao S, Ma Y, Huang X
International journal of clinical and experimental pathology 2015;8(9):10412-9
International journal of clinical and experimental pathology 2015;8(9):10412-9
Distinctions in gastric cancer gene expression signatures derived from laser capture microdissection versus histologic macrodissection.
Kim HK, Kim J, Korolevich S, Choi IJ, Kim CH, Munroe DJ, Green JE
BMC medical genomics 2011 Jun 2;4:48
BMC medical genomics 2011 Jun 2;4:48
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- human stomach tissue were subjected to SDS PAGE followed by western blot with 13734-1-AP(TFF1 antibody) at dilution of 1:400
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human stomach cancer using 13734-1-AP(TFF1 antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The Trefoil factor 1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human Trefoil factor 1. This antibody recognizes human antigen. The Trefoil factor 1 antibody has been validated for the following applications: ELISA, WB, IHC analysis.